Mike Hale speaks to Chirag Amin, general manager of Johnson & Johnson Vision Care UK, about his career to date and a recent ...
Americans wear contact lenses and 80% of them agree that contacts make them feel more like themselves, are you offering them the latest and greatest?
The US contact lenses market is expected to grow at a CAGR of $% from 2022 to 2028 with an increasing number of eye inaccuracies among the younger population.
With this new launch, the company widened its product portfolio. Johnson & Johnson Vision Care, Inc. introduced ACUVUE OASYS ...
Lento Bio Inc. has synthesized cysteine derivatives reported to be useful for the treatment of presbyopia. An exemplified compound (Cpd in row 4 in tbl1 pg 20, claim 18) decreased in lens stiffness in ...
Eye-focused biotechs Tenpoint Therapeutics and Visus Therapeutics are joining forces, setting their sights on filing a new drug approval application next year for a presbyopia-correcting eye drop.
The merger brings together a late-stage, potentially best-in-class, presbyopia-correcting eye drop, Brimochol PF (carbachol/brimonidine tartrate fixed-dose combination), on track for New Drug ...
“We want to minimise the difference patients feel between putting a fresh lens in and the end of the day. Our Acuvue Oasys Max technology is about building comfort into the day.” he said. A more ...